DJIA 16,493.37 -69.93 -0.42%
NASDAQ 4,352.64 -17.13 -0.39%
S&P 500 1,925.15 -5.52 -0.29%
market minute promo

Omeros (NASDAQ: OMER)

13.57 -0.04 (-0.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OMER $13.57 -0.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.59
Previous Close $13.61
Daily Range $13.06 - $13.99
52-Week Range $4.75 - $18.80
Market Cap $460.2M
P/E Ratio -8.90
Dividend (Yield) $0.00 (0.0%)
Volume 251,758
Average Daily Volume 407,139
Current FY EPS -$2.24

Sector

Healthcare

Industry

Drugs

Omeros (OMER) Description

Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system. Website: http://www.omeros.com/

News & Commentary

3 Under-the-Radar Biotech Stocks You Need to Watch in 2014

Nektar Therapeutics, Omeros, and Spectrum Pharmaceuticals all face off with regulators in key decision dates for their developmental drugs later this year

Omeros (OMER) Enters Overbought Territory - Tale of the Tape

Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape

Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape

Qualifying Speculation In Omeros Corporation

Omeros (OMER) Enters Overbought Territory - Tale of the Tape

Omeros' Omidria Gets FDA Nod - Analyst Blog

Benzinga's Top #PreMarket Gainers

2nd Half Of 2014 Biotechnology Catalysts: Part 1

Will St. Jude Medical (STJ) Surprise This Earnings Season? - Analyst Blog

Sector Update: Healthcare Shares Mixed Pre-Market; Vivus Sinks 5% on Piper Jaffray Downgrade

Sector Update: Healthcares

See More OMER News...

OMER's Top Competitors

OMER $13.57 (-0.29%)
Current stock: OMER
AMGN $125.55 (-1.44%)
Current stock: AMGN
GILD $91.50 (-0.05%)
Current stock: GILD
BIIB $329.83 (-1.36%)
Current stock: BIIB